175 related articles for article (PubMed ID: 11475815)
21. The "pill-in-the-pocket" approach to atrial fibrillation.
Wittkowsky AK
N Engl J Med; 2005 Mar; 352(11):1150-1; author reply 1150-1. PubMed ID: 15789456
[No Abstract] [Full Text] [Related]
22. [New aspects in the therapy of cerebrovascular diseases. Hemodynamic studies with a combination of coumarin-rutin-theophylline].
Klein K
Arzneimittelforschung; 1974 Jul; 24(7):1066-9. PubMed ID: 4408076
[No Abstract] [Full Text] [Related]
23. [Quality of life of patients given pharmacological treatment for atrial fibrillation].
Engelmann MD; Godtfredsen J
Ugeskr Laeger; 2004 Aug; 166(34):2877-82. PubMed ID: 15449523
[No Abstract] [Full Text] [Related]
24. Atypical calciphylaxis secondary to treatment with acenocoumarol.
Alvarez-Pérez A; Gutiérrez-González E; Sánchez-Aguilar D; Toribio J
Actas Dermosifiliogr; 2012 Jan; 103(1):79-81. PubMed ID: 22444506
[No Abstract] [Full Text] [Related]
25. Effect of oral anticoagulant therapy on fibrinolysis parameters in chronic non-rheumatic atrial fibrillation.
Roldán-Schilling V; Marín-Ortuño F; Marco-Vera P; Sogorb-Garri F
Haematologica; 2000 Jul; 85(7):778-80. PubMed ID: 10897143
[No Abstract] [Full Text] [Related]
26. How should we manage newly diagnosed atrial fibrillation?
Holten KB
J Fam Pract; 2004 Aug; 53(8):641-3. PubMed ID: 15298837
[No Abstract] [Full Text] [Related]
27. [Antivitamin K. Introduction].
Larcan A
Angeiologie; 1967; 19(5):33-5. PubMed ID: 5621970
[No Abstract] [Full Text] [Related]
28. Atrial fibrillation: more help for the most common arrhythmia.
;
JAAPA; 2007 May; 20(5):18, 21. PubMed ID: 17546939
[No Abstract] [Full Text] [Related]
29. Management of newly detected atrial fibrillation.
Lefevre ML
Am Fam Physician; 2004 May; 69(10):2314, 2316, 2321. PubMed ID: 15168954
[No Abstract] [Full Text] [Related]
30. [Double blind study on drug therapy of swellings and wound edemas following extremity fractures].
Imig H; Sinnokrot A
Med Welt; 1973 Apr; 24(14):547-8. PubMed ID: 4574295
[No Abstract] [Full Text] [Related]
31. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
[TBL] [Abstract][Full Text] [Related]
32. The combination of anticoagulant and anti-platelet therapy in patients with atrial fibrillation: a comment on the recent ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation.
Rubboli A; Di Pasquale G
Eur Heart J; 2006 Dec; 27(23):2908-9; author reply 2909-10. PubMed ID: 17074773
[No Abstract] [Full Text] [Related]
33. [Treatment of atrial fibrillation. Should we strive for restoration of sinus rhythm?].
Friberg J; Gadsbøll N
Ugeskr Laeger; 2004 Mar; 166(10):893-5. PubMed ID: 15045730
[No Abstract] [Full Text] [Related]
34. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
[TBL] [Abstract][Full Text] [Related]
35. Atrial fibrillation: rate versus rhythm control.
Amani F; Smith ES
J Ark Med Soc; 2005 Oct; 102(4):110-2. PubMed ID: 16265929
[No Abstract] [Full Text] [Related]
36. Acenocoumarol as an alternative anticoagulant in a patient with warfarin-related nephropathy.
Behera SK; Xavier AS; Selvarajan S; Munuswamy H; Haridasan S; Srinivas BH
Br J Clin Pharmacol; 2018 May; 84(5):1068-1071. PubMed ID: 29424022
[TBL] [Abstract][Full Text] [Related]
37. [New onset of atrial fibrillation--rate or rhythm control?].
Lewalter T
MMW Fortschr Med; 2009 Apr; 151(16):29, 31-2. PubMed ID: 19658292
[No Abstract] [Full Text] [Related]
38. National underuse of anti-thrombotic therapy in chronic atrial fibrillation identified from digoxin prescribing.
Mahmud A; Bennett K; Okechukwu I; Feely J
Br J Clin Pharmacol; 2007 Nov; 64(5):706-9. PubMed ID: 17555462
[TBL] [Abstract][Full Text] [Related]
39. Evolving developments in the therapeutics of atrial fibrillation: addressing an unmet need.
Nattel S
J Cardiovasc Pharmacol; 2008 Jul; 52(1):1-3. PubMed ID: 18594478
[No Abstract] [Full Text] [Related]
40. Verapamil, atrial fibrillation recurrences and anticoagulation.
Auer J; Weber T; Berent R; Eber B
Eur Heart J; 2004 Jan; 25(2):183-4. PubMed ID: 14720538
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
